MK-3475 and Gemcitabine in Non-Small Cell Lung Cancer (NSCLC)
MK-3475 and Gemcitabine in Non-Small Cell Lung Cancer (NSCLC)
Active, not recruiting · NCT02422381 · Registry updated 2026-02-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| MK-3475 and Gemcitabine in Non-Small Cell Lung Cancer (NSCLC) | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 1 / Phase 2 | 2026-02-18 | NCT02422381 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Merck Sharp & Dohme LLC | 650 |
| Providence Cancer Center, Earle A. Chiles Research Institute | 6 |
| Providence Health & Services | 35 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Providence Oncology & Hematology Care Clinic - Eastside | Portland | United States | 2 |
| Providence Oncology & Hematology Care Clinic - Westside | Portland | United States | 1 |